Mechanisms of action of antidepressants: From neurotransmitter systems to signaling pathways

Research output: Contribution to journalReview articlepeer-review

140 Scopus citations

Abstract

Antidepressants are commonly used in the treatment of anxiety and depression, medical conditions that affect ∼17-20% of the population. The clinical effects of antidepressants take several weeks to manifest, suggesting that these drugs induce adaptive changes in brain structures affected by anxiety and depression. In order to develop shorter-acting and more effective drugs for the treatment of anxiety and depression, it is important to understand how antidepressants bring about their beneficial effects. Recent reports suggest that antidepressants can induce neurogenesis in the adult brain, although the mechanisms involved are not clearly understood. In this review, we describe the different neurotransmitter systems that are affected by anxiety and depression and how they are modulated by antidepressant treatment with a focus on signaling molecules and pathways that are activated during neurotransmitter receptor induced neurogenesis.

Original languageEnglish
Pages (from-to)549-557
Number of pages9
JournalCellular Signalling
Volume17
Issue number5
DOIs
StatePublished - May 2005

Keywords

  • Anxiety
  • CRH
  • Cortisol
  • Depression
  • Neurogenesis
  • SSRI

Fingerprint

Dive into the research topics of 'Mechanisms of action of antidepressants: From neurotransmitter systems to signaling pathways'. Together they form a unique fingerprint.

Cite this